Transcription, beta-like DNA polymerases and hypermutation

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Immunoglobulin (Ig) gene hypermutation is a key process for antibody diversity.
• The precise molecular mechanisms driving Ig gene hypermutation remain incompletely understood.
• Previous models suggested a link between RNA polymerase pausing and error-prone repair during V gene transcription.

Purpose of the Study:

• To investigate the relationship between transcription elongation and Ig gene hypermutation.
• To identify novel DNA polymerases involved in the Ig hypermutation process.
• To characterize the expression and regulation of a candidate Ig mutase enzyme.

Main Methods:

• Introduction of a transcription termination signal into an Ig light chain transgene in transgenic mice.
• Analysis of transcription levels and mutation frequencies in control and mutant transgenes.
• Identification and characterization of novel DNA polymerases (Pol lambda and Pol mu) using molecular biology techniques.
• Assessment of Pol mu expression in lymphoid tissues and its similarity to known enzymes.
• Investigation of gene expression patterns, including splicing variability and response to DNA-damaging agents.

Main Results:

• Experimental data dissociated transcription elongation from mutation, challenging models reliant on RNA polymerase pausing.
• Two novel beta-like DNA polymerases, Pol lambda and Pol mu, were identified.
• Pol mu exhibited high lymphoid expression and structural similarity to terminal deoxynucleotidyl transferase, suggesting it as a strong candidate for the Ig mutase.
• Pol mu gene expression showed unusual splicing variability and inhibition upon DNA damage.

Conclusions:

• Transcription elongation is not a prerequisite for Ig gene hypermutation.
• Pol mu is a promising candidate enzyme responsible for Ig gene hypermutation.
• The regulation of Pol mu expression, including splicing, may be linked to DNA damage response pathways in lymphocytes.